NetworkNewsBreaks Archive - Page 495 of 1739

WednesdayJan 05, 2022 10:52 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces January 2022 Health Care Conference Schedule

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that it will present next week at the H.C. Wainwright Bioconnect Conference and the Biotech Showcase. The events are slated to be held virtually on Jan. 10-12, 2022. Tryp’s CEO and Chairman Greg McKee will provide an overview of the company and updates on its chronic pain and eating disorder programs. This year, all corporate presentations will be pre-recorded and available on-demand for registered attendees. In addition, replays of the presentations will be available on the Events section…

TuesdayJan 04, 2022 3:26 pm

NetworkNewsBreaks – Bassett Furniture Industries, Inc. (NASDAQ: BSET) Featured in Research Note from Sidoti

Earnings Preview; Estimates Lowered Bassett Furniture Industries (NASDAQ: BSET) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Supply Chain Issues, Higher Costs Likely Hurt 4Q:F21; Favorable Demand, Potential Supply Chain Normalization May Enable F2022, F2023 EPS Gains; Maintain Moderately Risky Rating, $36 Target.” Click here to access the full report. About Bassett Furniture Industries, Inc. Bassett Furniture Industries is a leading manufacturer and marketer of high-quality home furnishings. With 97 company and licensee-owned stores at the time of this release, Bassett has leveraged its strong brand name in furniture into…

TuesdayJan 04, 2022 2:26 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals One Drug Class at a Time

As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem. Lexaria is currently leading the industry in terms of innovation in drug delivery platforms. “Its patented DehydraTECH(TM) technology is specifically designed to improve how active pharmaceutical ingredients (‘APIs’) enter the bloodstream, ultimately increasing the effectiveness of fat-soluble molecules,” reads a recent article. The piece discusses Lexaria’s DehydraTECH as a product of years of research and millions in investments. Currently, the technology is covered by 23…

TuesdayJan 04, 2022 2:02 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Support Low-Cost/No-Cost Psychedelic Clinic for Underserved Communities

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones to revolutionize mental health care. Among these, the company recently secured a grant for the first-ever psychedelic treatment clinic at Lenox Hill Hospital. The hospital is part of Northwell Health, the largest health care system in New York State, and serves marginalized communities on the Upper East Side of Manhattan. Lenox Hill is working to become one of the first hospital-based clinical sites to offer psychedelic medicine in the United States. A recent article quotes Cybin Chief Clinical Officer Dr. Alex…

TuesdayJan 04, 2022 1:45 pm

NetworkNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks True Milestone in Development, Growth

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, recently completed the initial shipment of its sugarBEAT(R) continuous glucose monitor (“CGM”) devices to its U.K. licensee, MySugarWatch Limited. “MySugarWatch will market the sugarBEAT product under the MySugarWatch(R) brand and has developed a subscription-based diabetes coaching and management service packaged alongside the sugarBEAT monitor and related device sensors, an offering directed towards individuals diagnosed with type 2 diabetes,” reads a recent article. Previously placing an initial order for 5,000 CGM devices and 200,000 sensors, MySugarWatch anticipates a…

TuesdayJan 04, 2022 1:35 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Participation in Upcoming H.C. Wainwright Bioconnect Conference

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a life-sciences holding company dedicated to building a portfolio of assets and biotech solutions, will be involved in this month’s H.C. Wainwright Bioconnect Conference. The three-day conference is scheduled for Jan. 10–13, 2022. FSD Pharma interim CEO Anthony Durkacz will present at the conference; his presentation is scheduled for release on Jan. 10, 2022, at 7 a.m. ET, and will be available for conference attendees. Durkacz will also be available for one-on-one meetings with conference participants. To view the conference, visit https://nnw.fm/rt5hk To view the full press release, visit https://nnw.fm/KnKoE About FSD…

TuesdayJan 04, 2022 1:09 pm

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Engagement of Skyline Corporate Communications Group LLC for IR Services

FingerMotion (NASDAQ: FNGR), a mobile data and services company with evolving technology and a core competency in mobile payment and recharge platform solutions in China, today announced that it has recently retained the services of Skyline Corporate Communications Group LLC. Under the collaboration, Skyline will manage FingerMotion’s investor relations and corporate communications activities within the financial community. “Our Nasdaq listing along with our robust operating activities, growth objectives and expected corporate milestones prompted FingerMotion to select Skyline as our investor relations representative,” said Martin Shen, CEO of FingerMotion. “We believe that Skyline’s strong reputation, communications strategies, methodologies and standards are…

TuesdayJan 04, 2022 12:58 pm

NetworkNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Proprietary Medical Device Passes Registration Tests, Slated to Start Clinical Trial

AnPac Bio-Medical Science (NASDAQ: ANPC), a U.S.- and China-based biotechnology company focused on early cancer screening and detection, announced that its Class III medical device for lung cancer auxiliary diagnosis has passed stringent and rigorous registration tests; the tests were conducted at a testing laboratory selected by China’s regulatory agent for medical products, the National Medical Products Administration (“NMPA”). The device passed tests designed to measure accuracy, precision, stability, linearity, accuracy and repeatability in sample addition, cross-contamination, electromagnetic compatibility (“EMC”), and reliability and performance under various environmental conditions. According to AnPac Bio, completion of the tests is an important achievement…

TuesdayJan 04, 2022 12:17 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Foray into Mexico, Showcased in Latest Episode of ‘Bell2Bell’ Podcast

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, today announced that its Mind Naturals skincare brand has launched sales through Walmart.com and Coppel, a nationwide department store in Mexico. According to the update, the launch includes 12 products from the Mind Naturals portfolio, initially via e-commerce with subsequent plans to sell in brick-and-mortar retail locations. “We are excited to begin bringing high-quality, sustainable CBD skincare products to Mexico,” said Luis Merchan, CEO of Flora Growth Corp. “This agreement represents our first foray into the Mexican market and furthers our global foothold as a leader in…

TuesdayJan 04, 2022 10:36 am

NetworkNewsBreaks – Why Nowigence Inc. Is ‘One to Watch’

Nowigence, a fast-growing software-as-a-service (“SaaS”) company, develops and sells a ready-to-use artificial intelligence (“AI”) platform called Pluaris(TM). The platform is designed to automate reading and analysis of textual data, enabling individuals, teams and enterprises to quickly distill knowledge buried in narrative-intensive documents instantaneously from various public and private data sources. “Pluaris is created for those who want to read more in less time. It is a personal knowledge management (‘PKM’) tool that generates an annotated data feed based on topics of interest and automatically creates a permanent personal knowledge base from individual feeds and private uploads,” reads a recent article.…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks